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Biodegradable pH-responsive hydrogels for
controlled dual-drug release†
Liang Xu,a Linzi Qiu,a Yang Sheng,a Yixin Sun,a Linhong Deng,b Xinqing Li,c
Mark Bradley d and Rong Zhang *a
Dual-drug loaded pH-responsive hydrogels were prepared as a delivery system carrying, as exemplars, both
anti-cancer and anti-bacterial agents for pH controlled drug release. The hydrogels were composed of poly-
(L-lactide)-co-polyethyleneglycol-co-poly(L-lactide) dimethacrylates (with various molecular weights of L-lactide
oligomers) as a macromolecular crosslinker and copolymerized with acrylic acid and N-isopropylacrylamide. The
biodegradability, biocompatibility and mechanical properties of the hydrogels were characterized with the
hydrogels being nontoxic to cells, while showing a reversible480% reduction in volume at pH 1.2 compared to
pH 7.4. Drug release profiles showed differential release of tetracycline over doxorubicin at pH 1.2, with both
drugs being released equally at pH 7.4. Biodegradability was tunable by altering the crosslinking density and pH,
with the total degradation of the best gels observed within 2 weeks at pH 7.4.
Introduction
Hydrogels are a class of materials that consist of a three-
dimensional network of polymers which absorb large quantities
of water. Biodegradable hydrogels are typically soft materials and
have been used in multiple biomedical applications,1–4 such as
tissue engineering scaffolds and drug delivery carriers. They can
include biodegradable components such as poly(lactic acid)
(PLA),5 poly(e-caprolactone) (PCL),6 poly(D,L-lactide-co-glycolide)
(PLGA),7 and poly(e-caprolactone-co-lactide) (PCLA)8 as hydro-
phobic blocks copolymerized with hydrophilic components
such as poly(ethylene glycol) (PEG). Among the various classes
of hydrogels developed, the copolymers of poly(L-lactide)-co-
polyethyleneglycol-co-poly(L-lactide) (PLLA–PEG–PLLA) and their
derivatives show promising potential in a number of biomedical
applications, for example, withmaterials designed to form stable
self-assembling micellar structures9 with the hydrophobic core
allowing good loading of hydrophobic drugs, while also undergoing
biodegradation.10,11 Moreover, the biodegradability of the synthe-
sized PLLA–PEG–PLLA can be easily controlled by tuning the ratio of
the lactide to PEG during the ring-opening polymerization
process.12,13 For example PDLA–PLLA–PEG–PLLA–PDLA pentablock
copolymers have been synthesized and used for preparing micelles
for the release of doxorubicin (DOX) in a controlledmanner.14 Other
examples include drug encapsulation within nanogels15,16 and
liposomes,17,18 with biocompatible hydrogels attracting considerable
interest because of their low toxicity and biodegradability.19–22
Many hydrogels have been designed such that they respond
to external factors such as light, magnetic fields, and enzymes
or environmental factors such as pH and temperature. Examples
include: (a) multi-responsive hydrogels of poly(methacrylic acid-
co-N-vinylpyrrolidone) with a peptide crosslinker have been used
as drug carriers for the oral delivery of insulin, with hydrogels
retaining the insulin in simulated gastric fluid at pH 1.2, while
releasing it at pH 6.8 due to the trypsin triggered cleavage of the
peptide crosslinker.23 (b) Photo-responsive hydrogels have been
generated and used for controlled drug delivery.24 This includes
polymers that absorb light and undergo subsequent reversible
thermally induced changes (and cargo release) to polymers that
undergo irreversible bond cleavage and polymer dissolution.25
(c) In the area of ‘‘magnetic hydrogels’’ numerous polymers have
been designed26 including magnetic hydrogel materials designed to
be magnetically localized and those that are designed to undergo
magnetically activated swelling, aggregation or degradation with the
release of growth factors.27 (d) The broad difference in pH between
the stomach and other parts of the gastrointestinal (GI) tract allows
pH-sensitive drug delivery systems to selectively deliver drugs. For
example, the targeting of specific disease sites in the GI tract for local
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drug release or uptake/delivery of the drug via, for example, the small
intestine. pH responsive polymers include: the block copolymer
polyamidoamine–PLLA–PEG which forms micelles that show con-
trolled drug release when the pH is low, while retaining the drug at
pH 7.4;28 poly(L-histidine)–PEG block copolymers which whenmixed
with PLLA–PEG generate micelles for controlled drug release, with
the dissolution of the poly(L-histidine)–PEG and swelling of the
micelles at pH 6.29 Another pH sensitive material generated from
the grafted copolymer of poly(N-isopropyl acrylamide-co-methacrylic
acid)-g-PLA has also been used to prepare multifunctional micelles
for cancer cell targeting and anticancer drug delivery.30 (e) In addition
smart drug carriers with dual environmentally responsive behaviours
are being developed. Thus a pH and temperature sensitive hydrogel
prepared from dextrin and poly(acrylic acid) has been used for
sustained release of ornidazole and ciprofloxacin.31 Some block
copolymers show sol–gel transitions when the temperature is
increased to37 1C,32,33 and thesepolymershavebeenused fordissolu-
tion of an anticancer drug with subsequent gelation upon injection.
In recent years, combination therapies have attracted much
attention with the co-use of multiple drugs having both different
therapeutic34,35 and/or synergistic33,36,37 effects. However the con-
trolled dual administration of multiple drugs, each with their own
distinct physical and chemical properties, is challenging. A hydrogel/
micelle composite prepared from PEG and poly(vinyl alcohol) (PVA)
with embedded tramadol, and oleic acid-g-chitosan copolymer
micelles loaded with the antibiotic cefixime was developed as a
dual-drug release carrier38 allowing efficient release of two very
different drugs. A drug carrier prepared from a CS/PVA hydrogel
encapsulating aspirin and poly(L-glutamic acid)-b-poly(propylene
oxide)-b-poly(L-glutamic acid) micelles entrapping DOX showed
independent release behaviour of each drug.39
Dual drug release from hydrogels has been reported with the
covalent attachment of polymeric micelles that possessed dif-
ferent drug release profiles.34 pH sensitive protein–carbopol–
polyacrylamide based hydrogels have been used to encapsulate
a combination of antimalarial drugs (one highly water soluble
and the other highly insoluble) with the hydrogel allowing
controlled delivery/release of both drugs.40
Here hydrogels were designed to act as pH responsive ‘‘smart
drug carriers’’ to allow controlled dual drug release, with materials
fabricated using poly(L-lactide)-co-polyethyleneglycol-co-poly(L-lactide)
dimethacrylates (MA–PLLA–PEG–PLLA–MA) as degradable poly-
meric crosslinkers along with the monomers acrylic acid (AA) and
N-isopropylacrylamide (NIPAM). As model compounds the anti-
cancer drug DOX and the antibiotic tetracycline (TET)41,42 were
loaded into the hydrogels with the dual drug loading efficiency
and in vitro drug release at pH 7.4 and 1.2 examined. Experiments
demonstrated that the dual-drug loaded hydrogels released drugs
under differing conditions and successfully killed HeLa cells while
inhibiting the growth of Escherichia coli.
Experimental
Materials
L-Lactide (LLA) was obtained from Sinobiom and recrystallized
from dry ethyl acetate before use. PEG (Mw 4000) and NIPAM
were purchased from Aldrich. Stannous 2-ethyl-hexanoate (Sn(Oct)2),
methacrylic anhydride and Irgacure 2959 were purchased from Aike,
and used as received. Dichloromethane and triethylamine (TEA)
were dried over calcium hydride and distilled prior to use.
Doxorubicin and tetracycline were purchased from MeilunBio.
Synthesis of MA–(PLLA–PEG–PLLA)–MA
PEG (20 g, 5 mmol) and appropriate amounts of L-lactide (mole
ratios used were 1 : 2 and 1 : 5) were mixed with the catalyst
(3 wt% of total monomer weight) and heated for 12 h at 130 1C.
The reaction mixture was cooled to room temperature and the
solid was dissolved in dichloromethane (50 mL) before pouring
the solution into excess diethyl ether. The precipitate was
collected via centrifugation and the polymer diols were dried
at 40 1C under vacuum for 24 hours. The PLLA–PEG–PLLA diols
(20 g) were dissolved in 100 mL of dichloromethane, and
triethylamine and methacrylic anhydride in dichloromethane
(10 mL) were added dropwise (the molar ratio of PLLA–PEG–
PLLA : TEA :MA was 1 : 4 : 4) and reacted at 30 1C for 48 hours to
give the end-capped polymer diols (MA–PLLA–PEG–PLLA–MA) as
reported by Lee.11 The product was recovered via precipitation
from a mixture of cold ether/hexane/methanol (10/1/1, v/v/v).
Polymer characterization
The polymers were characterized using FTIR (Nicolet Avatar 370
spectrophotometer, Nicolet) and 1HNMR (AVANCEIII-400 spec-
trometer, 400 MHz) in CDCl3 (see the ESI†). The molecular
weights and polydispersity were measured using GPC (Waters
Alliance 515) with THF as the eluent with a flow rate of
1 mL min1 on a Waters Styragel HR column calibrated using
polystyrene standards.
Preparation of hydrogels based on MA–PLLA–PEG–PLLA–MA
Hydrogels were prepared using MA–PLLA–PEG–PLLA–MA, AA and
NIPAM in various ratios (Table 1). Thus MA–PLLA–PEG–PLLA–MA,
AA and NIPAM were dissolved in deionized water (1.5 g) and 1 wt%
of the photoinitiator I2959 (relative to the total mass of monomers).
The solution was stirred under nitrogen for 30 min before being
cast onto PTFE molds (12 mm in diameter, thickness 1 mm) and
photo-polymerized under 365 nmUV light (SB-100P/FA) for 10min.
The hydrogels were soaked in 50 mL of distilled water for 48 hours
to remove impurities or unreacted monomers before drying in a
vacuum oven at 50 1C to a constant weight.
Preparation of dual-drug loaded hydrogels
Each molded hydrogel ‘‘pellet’’ was submerged into phosphate-
buffered saline (PBS, 8 mL, pH 7.4) containing DOX (50 mM)
and TET (198 mM) in a 12-well plate for 48 hours. The hydrogel
was removed to a new plate and the remaining drug was
quantified (496 nm for doxorubicin and 361 nm for tetracycline)
(for details please see the Methods section and Fig. S5 and S6 in
the ESI†).
Scanning electron microscopy (SEM)
SEM was used to visualize the morphology of the hydrogels.
The hydrogels were immersed in deionized water at pH 1.2
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(simulated gastric fluid) and pH 7.4 (simulated intestinal fluid)
respectively for 48 hours and then frozen in liquid nitrogen
before lyophilization for 48 hours. The cross-sections of the
freeze-dried specimens were then sputtered with gold for
60 seconds before analysis via SEM (JSM-6510).
Swelling analysis of hydrogels in buffers of various pHs
The swelling ratios of hydrogels weremeasured using a gravimetric
method. The cylindrical hydrogel samples were immersed in PBS
buffers at various pH values (pH 1.2, 4.0, 5.0, and 7.4) at 37 1C for
48 h. The samples were removed and excess fluid removed with
filter paper before weighing (see the ESI†). The swelling behavior
of the hydrogels was similarly studied at pH 1.2 after 0.5, 1, 2, 4, 8
and 12 h and at pH 7.4 after 0.5, 1, 2, 4, 8 and 12 h (n = 3).
In vitro biodegradation of the hydrogels
The degradation was studied by immersing the hydrogel pellets
(50.9  1.1 mg) in PBS (8 mL, 10 mM) at pH 7.4 or 1.2. The
hydrogels were removed from the degradation solution at
designed time points, washed with distilled water and dried
to a constant weight in a 50 1C vacuum oven (see the ESI†).
In vitro dual drug release
To measure the amount of released doxorubicin and tetracycline,
the dual-drug loaded hydrogels were immersed at pH 1.2 or 7.4 at
37 1C with stirring (100 rpm). 4 mL of the solution from each vial
was removed for analysis (absorbance at 496 nm and 361 nm) and
replaced with an equal volume of the solution. The cumulative
release of drugs was calculated (see the ESI†).
Result and discussion
Polymer synthesis and characterization
MA–PLLA–PEG–PLLA–MA was prepared and used as a macro
cross-linker instead of the traditionally used small molecular
cross-linkers such as N,N0-methylenebisacrylamide or glutaral-
dehyde to improve the hydrophobic properties and degradation
abilities of the hydrogels to make them suitable for biological
applications (Scheme 1 and Table 2). The synthesized polymers were
characterized using 1H-NMR: the chemical shifts for resonance
signals were assigned to the corresponding protons on PLLA–
PEG–PLLA diols (Fig. 1a) including: 1.4 (m, CH(CH3)OH, end
Table 1 The hydrogels synthesized with various monomer/cross-linker
combinations
Polymers
(MA–PLLA–PEG–PLLA–MA)-2 or
5 : AA :NIPAM (wt%/molar ratio)a
S1 70:30 : 0/1 : 40 : 0
S2 55 : 25 : 20/1 : 42 : 22
S3 40 : 20 : 40/1 : 46 : 59
S4 55 : 25 : 20/1 : 46 : 23
S5 40 : 20 : 40/1 : 51 : 65
a Polymers S1–S3 used the macro cross-linker (MA–PLLA–PEG–PLLA–
MA)-2 with PEG : LLA (1 : 2 (mol mol1)) and polymers S4 and S5 used
the macro cross-linker (MA–PLLA–PEG–PLLA–MA)-5 with PEG : LLA
(1 : 5 (mol mol1)).
Scheme 1 Preparation of the macro crosslinker MA–PLLA–PEG–PLLA–MA.
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group of PLLA), 1.5 (m, CHCH3 of PLLA), 3.6 (m, CH2–O–CH2
of PEG), 4.2–4.3 (m, CH2OCO, linking unit of PEG–PLLA),
and 4.3–4.4 (q, CH(CH3)OH), 5.2 (m, CHCH3). The chemical
shifts of protons on MA–PLLA–PEG–PLLA–MA included 1.4
(m, CH(CH3)OCO, end group of PLLA), 1.5 (m, CHCH3 of PLLA),
1.9 (s, C(CH3)QCH2), 3.6 (m, CH2–O–CH2 of PEG), 4.2–4.3
(m, CH2OCO, linking unit of PEG–PLLA), 4.3–4.4 (q, CH(CH3)OCO),
5.2 (m, CHCH3), and 5.6 and 6.2 ((CH3)CQCH2) (Fig. 1b). FTIR
analysis also indicated that the polymer diols and MA–PLLA–
PEG–PLLA–MA were successfully prepared (see Fig. S1 in the
ESI†). The molecular weight and chemical structure of polymer
diols and their end-capped cross-linkers were calculated using
1HNMR. As shown in Fig. 1, the chemical shifts at 4.3–4.4
(CH(CH3)OCO–) correspond to the protons of the LLA units and
those at 3.6 (–CH2–O–CH2–) correspond to the protons of the
ethylene glycol units. Based on integration of the peak areas,
the number of repeating units (n) of LLA and the molecular
weight of the diols could be calculated (Table 2).45 The mole-
cular weights and polydispersity (PDI) of the synthesized poly-
mers were also determined using GPC (Table 2), with the
molecular weights of the PEG successfully increased by adjust-
ing the molar ratio of LLA to PEG4000 from 2 : 1 to 5 : 1. The
results indicate that the Mn (NMR) values of the synthesized
polymers were close to the theoretical molecular weight, while
GPC analysis gave PDIs of about 1.1. Not surprisingly the GPC
results of the polymer diols virtually overlapped with that of the
functionalized MA–PLLA–PEG–PLLA–MA (see Fig. S2 in the ESI†).
Swelling properties of the hydrogels
Hydrogels consisting of MA–PLLA–PEG–PLLA–MA, AA and
NIPAM were prepared using a light mediated free radical
polymerization approach in high yield (see Fig. S3 in the ESI†).
The physical and chemical properties of the hydrogels could be
tuned using MA–PLLA–PEG–PLLA–MA with different molecular
weights of the PLLA segments. The swelling ratios of the
hydrogels in aqueous media were shown to play important
roles in their biodegradation behaviour. The variation of the
swelling ratios for all hydrogels was small (less than one-fold
increase) when increasing the pH from 1.2 to 5.0, although S4
was the most hydrophilic with about 500% swelling at pH 1.2. A
critical change occurred when the pH was increased from 1.2 to
7.4 with the swelling ratios of the hydrogels increasing some
3.0 (S1), 2.9 (S2), 3.2 (S3), 3.6 (S4) and 8.4 (S5) fold. The rational
for this increase in the swelling ratio with pH is presumably
due to ionization and subsequent repulsion between the
poly(acrylic acid) units at pH 7.4, which makes the hydrogels
hydrophilic. These results indicate that the molecular weight of
MA–PLLA–PEG–PLLA–MA influences the pH response of the
hydrogels, with MA–PLLA–PEG–PLLA–MA with the highest
molecular weight showed the largest swelling ratio as the pH
increased to 7.4 (Fig. 2A).
The reversible swelling (pH 7.4) and de-swelling (pH 1.2) of
the hydrogels could be repeated over many cycles (Fig. 2B) with
the hydrogels shrinking dramatically over 2 hours with some of
them (i.e. S3, S5) becoming opaque (Fig. 2C) showing the
formation of a hydrophobic phase in the gels. The transmittance
of the hydrogels changed as the temperatures increased above
25 1C, showing the existence of a lower critical solution temperature
(LCST) (see Fig. S4 in the ESI†). The LCST of the hydrogels showed
an abrupt change when the hydrogels had more NIPAM and less
MA–PLLA–PEG–PLLA–MA, such as hydrogels S3 (31 1C) and S5
(29 1C) which were hydrophobic with low swelling ratios in acidic
buffers at 37 1C. The LCST of S4 was 36 1C and the polymer was
transparent at room temperature. The average pore size, measured
from SEM images of the frozen dried hydrogels (Fig. 2D and E)
showed at pH 7.4 was ca. 8 mm in diameter, which reduced to ca. 2
mm or less at pH 1.2.
In vitro degradation of the hydrogels
As shown in Fig. 3A and B, hydrogels S4 and S5 degrade more
quickly than the other three samples presumably because the
low cross-linking density allows greater buffer accessibility and
resulted in faster swelling and degradation.
At pH 7.4 the degradation rate increased with the reduction
of the macro cross-linker loading (S1 o S2 o S3 (70%/55%/
40%)), while at pH 1.2 the degradation rate was inverted
(S1 4 S2 4 S3) (Fig. 3C). Ester hydrolysis can be either acid
or base mediated, while solvent accessibility and polymer
mobility are also important features as is internal catalysis in
Table 2 Molecular weight and polydispersity index of the synthesized
PLLA–PEG–PLLA diols and MA–PLLA–PEG–PLLA–MAs
Polymer Yield (%)
Molecular weight
Theory 1H-NMR
GPC
Mn PDI
PLLA–PEG–PLLA-2 91 4288 4136 6400 1.12
MA–PLLA–PEG–PLLA–MA-2 85 4442 4410 6700 1.11
PLLA–PEG–PLLA-5 93 4720 4484 7000 1.14
MA–PLLA–PEG–PLLA–MA-5 82 4874 4808 7300 1.13
Note: the theoretical molecular weight was calculated from the monomer
inputs. The actual molecular weight was calculated via 1H-NMR following
our reported method.43
Fig. 1 1H-NMR spectra of: (a) PLLA–PEG–PLLA copolymer diols and (b)
the macro cross-linker MA–PLLA–PEG–PLLA–MA, both in CDCl3.
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the form of carboxylic acid groups. Not unexpectedly it was
found that the buffer became acidic after two weeks of hydrogel
degradation due to ester hydrolysis (Fig. 3D) – an observation
commonly found around PLA based implants.
Drug release from the hydrogels
Analysis of the drug loading of the hydrogels (Fig. 4 and Fig. S5,
S6 in the ESI†) showed that the hydrogels typically loaded more
DOX than TET. This was probably through hydrophobic inter-
actions and aggregation with the PLLA segments in the hydro-
gels because DOX (log p 2.82) is more hydrophobic than TET
(log p 1.47). S4 and S5 with the longer crosslinkers loaded
more TET than other hydrogel samples. As for DOX, the ratio of
the macro crosslinker and NIPAM was an important factor that
influenced drug loading, with S2 loading similar amounts of
DOX as S5.
Drug release experiments showed that DOX was released
less at pH 1.2 than that at pH 7.4 (Fig. 5 and Fig. S7 in the ESI†)
with the accumulative release of only 20–23% after 10 hours in
PBS at pH 1.2 for hydrogels S1 and S2, while it increased to 52%
at pH 7.4 after 10 hours (Fig. 5A and B). The drug release from
S3, S4 and S5 was 43%, 42% and 47%, respectively, under acidic
conditions; however, this was increased to 62% for S3 and S5
and 52% for S4 at pH 7.4. The reason why hydrogels S3, S4 and
S5 released more than S1 and S2 at pH 1.2 is probably due to
several reasons: firstly the levels of the macro crosslinker in S3
or S5 were less than those in S1 or S2, with more DOX released
from the ‘‘looser’’ hydrogels at pH 1.2;44 secondly, although the
macro crosslinker of S4 was similar to that of S2, the swelling
Fig. 2 Properties of the hydrogels. (A) Equilibrium water content of hydrogels at various pH values at 37 1C, n = 3; (B) swelling of the hydrogels with
switching between pH 7.4 (high swelling ratios) and 1.2 (low swelling ratios) at 37 1C; (C) images of the hydrogels at pH 7.4 (upper) and 1.2 (lower) at
equilibrium; (D) SEM images of hydrogels swollen at pH 7.4 and (E) pH 1.2 and then frozen and lyophilized. The average pore size of hydrogels was
calculated using Image J.
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ratio at pH 1.2 was larger than S2 or S1 (Fig. 2A), thus more DOX
was released from S4. However, the TET release profiles of
hydrogels told a very different story (Fig. 5C and D). In acidic
buffer, the accumulative release increased from 65% for S1 to
95% for S5, with the drug release from S4 and S5 reaching
495% in just 2 hours. The TET release at pH 7.4 ranged from
60 to 78% for S1–S5.
The drug loaded hydrogels S1–S5 released 31–61% of the
doxorubicin cargo into the supernatant after 12 hours (see
Fig. S9 in the ESI†). This doxorubicin, liberated from the
hydrogel carriers, was effective in killing HeLa cells and showed
analogous levels of cell death to the equivalent level of free DOX
(Fig. S9C in the ESI†). The cytotoxicity of the hydrogels themselves
was evaluated in a CCK-8 assay with the degraded polymers
showing low toxicity to cells (see Fig. S8 in the ESI†), in agreement
with the results of the other hydrogels.45,46
Antibacterial experiments showed that the dual-drug loaded
hydrogels formed inhibition zones on agar surfaces coated with
E. coli after 24 h of incubation (see the Methods section, Fig. S10 in
the ESI†). S4 and S5 weremore effective in bacterial killing than the
other three hydrogel samples (while no inhibition zone was formed
around the controls), agreeing with the above results that S4 and S5
loaded more TET than the other hydrogels (Fig. 4).
The mechanical properties of the hydrogels were analyzed
via compressive tests and rheological measurements (see
Fig. S11 in the ESI†) and showed that the hydrogels were stable,
cross-linked hydrogels with compressive moduli ranging from
110 KPa (S1) to 4 KPa for S5.
Conclusions
In summary, degradable copolymers MA–PLLA–PEG–PLLA–MA
were synthesized and characterized and used as macro cross-
linkers in the generation of hydrogels for the entrapment of two
model drugs. The dual-drug loaded hydrogels based on MA–
PLLA–PEG–PLLA–MA, AA and NIPAM showed that biodegradability
Fig. 3 Biodegradation analysis of hydrogels. (A) The biodegradable behavior of the hydrogels at pH 7.4 with S4 and S5 showing total degradation after 6
and 8 weeks, respectively; (B) the biodegradable behavior of the hydrogels at pH 1.2; (C) the difference in the biodegradation rate of the hydrogels (S1–3)
in various environments; and (D) the pH value change of the degradation buffers when the hydrogels degraded in PBS (beginning at pH 7.4) after 2 weeks.
Fig. 4 Dual-drug loading of hydrogels. The dual-drug solutions used for
the drug loading were 50 mM DOX and 200 mM TET in PBS (pH 7.4). The
errors are STDEV and n = 3.
Paper Journal of Materials Chemistry B
516 | J. Mater. Chem. B, 2018, 6, 510--517 This journal is©The Royal Society of Chemistry 2018
of the hydrogels could be controlled using specific macromolecular
cross-linkers with appropriate molecular weights. Analysis showed
that the hydrogels were pH sensitive, with all the hydrogels
shrinking at pH 1.2 and swelling at pH 7.4. At pH 7.4 the
hydrophobicity was an important factor that controlled degradation
rate, with hydrogels with higher levels of hydrophobic segments
(like S1) degrading more slowly than the less hydrophobic S3. On
the other hand, at pH 1.2 all of the hydrogels became more
hydrophobic and [H+] became an important factor in controlling
the degradation rate of the hydrogels – presumably by catalyzing
and accelerating the hydrolysis of the polyester cross-linker. Higher
percentages of the macro cross-linker in hydrogels such as in S1
lead to more rapid degradation. The influences of pH and mono-
mer combination on the swelling ratio and drug-releasing rate of
the hydrogels were examined using simulated gastric fluid (pH 1.2)
and simulated intestinal fluid (pH 7.4). The release of DOX was
considerably slower at pH 1.2 than that at pH 7.4 due to the
hydrophobic hydrogel preventing the drug from quickly dissolving/
being liberated from the scaffold, while the liberated DOX was
effective in killing HeLa cells. TET was ‘‘burst released’’ from the
hydrogels at pH 1.2 due to the hydrophilicity of the drug. An
antibacterial study showed that the hydrogels loaded with TET
liberated the antibacterial agent and killed E. coli in a disk diffusion
assay. The hydrogels’ pH mediated differential drug release func-
tionality (slow release of DOX in acidic buffers and the rapid release
of TET) shows that the hydrogels have interesting drug carrier
properties. TET showed a ‘‘burst release’’ behaviour at pH 1.2
(analogous to the stomach region) especially for hydrogels S4
and S5 over the first 1–2 hours, whilst most of the DOX was
retained in the hydrogels at pH 1.2 and it was released at pH 7.4
(the pH found in the intestine or colon). This differential release
profile of two drugs could thus be of benefit for the delivery of
specific individual drugs to specific GI sites following, for
example, oral administration.
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